1. Home
  2. ANIP vs IHS Comparison

ANIP vs IHS Comparison

Compare ANIP & IHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANIP
  • IHS
  • Stock Information
  • Founded
  • ANIP 2001
  • IHS 2001
  • Country
  • ANIP United States
  • IHS United Kingdom
  • Employees
  • ANIP N/A
  • IHS N/A
  • Industry
  • ANIP Biotechnology: Pharmaceutical Preparations
  • IHS Telecommunications Equipment
  • Sector
  • ANIP Health Care
  • IHS Telecommunications
  • Exchange
  • ANIP Nasdaq
  • IHS Nasdaq
  • Market Cap
  • ANIP 1.2B
  • IHS 1.1B
  • IPO Year
  • ANIP N/A
  • IHS 2021
  • Fundamental
  • Price
  • ANIP $55.67
  • IHS $3.23
  • Analyst Decision
  • ANIP Buy
  • IHS Strong Buy
  • Analyst Count
  • ANIP 7
  • IHS 6
  • Target Price
  • ANIP $77.33
  • IHS $9.42
  • AVG Volume (30 Days)
  • ANIP 253.7K
  • IHS 481.7K
  • Earning Date
  • ANIP 11-08-2024
  • IHS 11-12-2024
  • Dividend Yield
  • ANIP N/A
  • IHS N/A
  • EPS Growth
  • ANIP N/A
  • IHS N/A
  • EPS
  • ANIP N/A
  • IHS N/A
  • Revenue
  • ANIP $555,456,000.00
  • IHS $1,783,187,000.00
  • Revenue This Year
  • ANIP $25.49
  • IHS N/A
  • Revenue Next Year
  • ANIP $19.92
  • IHS $1.75
  • P/E Ratio
  • ANIP N/A
  • IHS N/A
  • Revenue Growth
  • ANIP 23.60
  • IHS N/A
  • 52 Week Low
  • ANIP $52.00
  • IHS $2.18
  • 52 Week High
  • ANIP $70.81
  • IHS $4.79
  • Technical
  • Relative Strength Index (RSI)
  • ANIP 42.29
  • IHS 54.63
  • Support Level
  • ANIP $55.29
  • IHS $3.16
  • Resistance Level
  • ANIP $57.33
  • IHS $3.39
  • Average True Range (ATR)
  • ANIP 1.88
  • IHS 0.14
  • MACD
  • ANIP -0.16
  • IHS -0.01
  • Stochastic Oscillator
  • ANIP 5.34
  • IHS 24.44

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid dose products. Its areas of product development include narcotics, oncolytic, hormones and steroids, and complex formulations involving extended release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

About IHS IHS Holding Limited

IHS Holding Ltd is an independent owner, operator, and developer of shared telecommunications infrastructure. The company provides telecommunications infrastructure to its customers, most of who are MNOs, who in turn provide wireless voice and data services to their end-users. Its geographical segments are Nigeria, Sub-Saharan Africa, Middle East and North Africa (MENA), and Latin America (Latam). The majority of its revenue is derived from Nigeria.

Share on Social Networks: